On the stock market since 2017, it operates in the world of health and science. It has 295 employees. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
If every debt were paid off today, $818.5M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
This grade is a blend: the profit side is strong, the sales tempo slow.
The stock has been running stronger than the market lately.
No real weak spot in any of the five subjects — a balanced report card.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades below its recent peak — about 10% off the top. A pullback, not a collapse.
The net profit margin is 53% — that slice of every sale is the company’s cushion in hard quarters.
There is $827.8M in the vault; even if every debt were paid off, $818.5M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
The company’s market value is 49 times its annual profit. Even a small disappointment could hit the price hard.
Over the last 12 months, executives reported 164 sells against just 23 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, KRYS sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: KRYS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.